Novel Oral Anticoagulants for DC Cardioversion Procedures: Utilization and Clinical Outcomes Compared with Warfarin

ConclusionIn a high volume single center experience, NOAC utilization has grown to account for over a third of cardioversion procedures, and these agents appear safe and effective compared to warfarin with low rates of thromboembolic and bleeding complications.This article is protected by copyright. All rights reserved.

Source: Pacing and Clinical Electrophysiology : PACE - February 1, 2015 Category: Cardiology Authors: COREY M. COLEMAN, SHADEN KHALAF, STEVEN MOULD, OUSSAMA WAZNI, MOHAMED KANJ, WALID SALIBA, DANIEL CANTILLON Tags: Original Source Type: research